Get the Stockscreener App
22.52
2.83%
0.625
Progyny Inc stock is traded at $22.52, with a volume of 375.32K.
It is up +2.83% in the last 24 hours and down -0.04% over the past month.
See More
Previous Close:
$21.90
Open:
$22.13
24h Volume:
375.32K
Relative Volume:
0.22
Market Cap:
$1.91B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
35.75
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+2.13%
1M Performance:
-0.04%
6M Performance:
+34.37%
1Y Performance:
-40.97%
1-Day Range:
$22.11
$22.79
1-Week Range:
$21.36
$22.79
52-Week Range:
$13.39
$37.92
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
22.52 | 1.91B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
522.18 | 476.52B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
436.28 | 98.20B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
329.77 | 89.74B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.58 | 85.19B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
263.32 | 32.63B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny expands maternal health offerings with doula services - Investing.com India
Progyny expands materna health support with doula services - TipRanks
Progyny Expands Maternal Health Support with Addition of Doula Services - GlobeNewswire
BTIG Upgrades Progyny to Buy From Neutral, Price Target is $28 - Marketscreener.com
BTIG lifts Progyny stock rating to Buy, sets $28 target - Investing.com India
The past three years for Progyny (NASDAQ:PGNY) investors has not been profitable - Yahoo Finance
Commit To Buy Progyny At $17.50, Earn 12.7% Annualized Using Options - Nasdaq
James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Progyny Clears Key Benchmark, Hitting 80-Plus RS Rating - MSN
The three-year loss for Progyny (NASDAQ:PGNY) shareholders likely driven by its shrinking earnings - Simply Wall St
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com UK
How the (PGNY) price action is used to our Advantage - Stock Traders Daily
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering - GlobeNewswire
Progyny launches Parent and Child Well-being Offering - TipRanks
Progyny Tackles 40% of Workforce Needs with Game-Changing Parent Support Solution - StockTitan
Mutual of America Capital Management LLC Has $194,000 Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny at Leerink’s Global Healthcare Conference: Strategic Expansion Focus By Investing.com - Investing.com Canada
Progyny, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire
Exclusive Access: Progyny Leadership Reveals Growth Strategy at Triple Healthcare Conference Series - StockTitan
Amalgamated Bank Sells 1,468 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Truist Financial Corp Cuts Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus.com
Progyny, Inc. SEC 10-K Report - TradingView
Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best - The Globe and Mail
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Progyny, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
Principal Financial Group Inc. Sells 419,185 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Rhumbline Advisers Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook - TipRanks
Progyny (NASDAQ:PGNY) Issues Earnings Results, Misses Estimates By $0.28 EPS - MarketBeat
Progyny (NASDAQ:PGNY) Issues Q1 2025 Earnings Guidance - MarketBeat
Expert Outlook: Progyny Through The Eyes Of 4 Analysts - Benzinga
Progyny price target raised to $23 from $17 at Canaccord - TipRanks
Progyny Tops EPS Forecast, Eyes Growth - MSN
KeyBanc maintains Progyny stock Sector Weight amid strong outlook - Investing.com India
KeyBanc maintains Progyny stock Sector Weight amid strong outlook By Investing.com - Investing.com South Africa
Progyny Tops EPS Forecast, Eyes Growth - The Motley Fool
Cantor Fitzgerald raises Progyny stock target to $26 By Investing.com - Investing.com Canada
Progyny projects slower revenue growth after losing Amazon - Crain's New York Business
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges - Investing.com India
Cantor Fitzgerald raises Progyny stock target to $26 - Investing.com
Canaccord raises Progyny stock price target to $23, maintains hold By Investing.com - Investing.com Australia
Progyny, Inc. (NASDAQ:PGNY) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Progyny stock price target to $23, maintains hold - Investing.com India
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges By Investing.com - Investing.com South Africa
Progyny Inc (PGNY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Progyny Reports Strong Q4 2024 Growth and Surpasses Revenue ExpectationsNews and Statistics - IndexBox, Inc.
Progyny, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 -February 27, 2025 at 04:09 pm EST - Marketscreener.com
Progyny: Q4 Earnings Snapshot - mySA
Progyny stock soars 16.9% on earnings beat, strong guidance By Investing.com - Investing.com Australia
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):